Immediate Impact
66 standout
Citing Papers
NAFLD and NASH: etiology, targets and emerging therapies
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Works of Anela Kellogg being referenced
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Anela Kellogg | 110 | 33 | 14 | 91 | 33 | 8 | 250 | |
| Maurizio D’Abbraccio | 141 | 20 | 1 | 46 | 32 | 13 | 247 | |
| Alexander Sarnowski | 54 | 18 | 5 | 57 | 10 | 12 | 202 | |
| Ravi Menon | 96 | 25 | 9 | 61 | 14 | 12 | 280 | |
| Lourdes García | 49 | 31 | 1 | 97 | 10 | 15 | 246 | |
| Evangelia Koutli | 157 | 85 | 19 | 40 | 7 | 8 | 273 | |
| Bryan Wilner | 59 | 10 | 2 | 116 | 45 | 12 | 282 | |
| Xiuping Hu | 119 | 8 | 154 | 32 | 9 | 295 | ||
| Fabian Meienberg | 99 | 7 | 1 | 45 | 25 | 17 | 266 | |
| Helena Stockmann | 143 | 63 | 7 | 55 | 19 | 14 | 296 | |
| Siva H. Yedlapati | 30 | 17 | 5 | 90 | 16 | 13 | 262 |
All Works
Loading papers...